Mode
Text Size
Log in / Sign up
N/A N=127 Randomized Treatment

Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients

Rib Fractures

Enrolled (actual)
127
Serious AEs
21.8%
Results posted
Mar 2026
Primary outcome: Primary: Acute Pain Assessed by Numeric Pain Score — 5.61; 5.93 score on a scale — p=0.493

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cryoneurolysis (Radiation); Standard of Care (Other)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
Stanford University
Primary completion
Apr 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Acute Pain Assessed by Numeric Pain Score
5.61; 5.93 0.493
SECONDARY
30-day Mortality
0; 0
SECONDARY
Number of Participants Requiring ICU Admission
6; 6 0.947
SECONDARY
Length of Hospital Stay
4; 5.5 0.77
SECONDARY
Use of Narcotic Equivalents
24.11; 15.00; 0; 0; 0; 0 0.285
SECONDARY
Number of Participants With a Rib-specific Readmission Within 30 Days of Discharge
0; 1 0.293
SECONDARY
The McGill Pain Questionnaire (MPQ) and Pain Rating Index (PRI) Scale Score
2.72; 1.73; 4.64; 1.50; 1.15; 0.41 0.042 sig
SECONDARY
The Glasgow Outcome Scale Extended (GOS-E) Score
2; 0; 13; 17; 3; 1 0.698
SECONDARY
Short Form (SF-12) Health Survey Scale Score
32.93; 29.89; 55.14; 55.65; 51.38; 47.96 0.962

Summary

The purpose of this study is to provide long-term pain control for elderly patients with rib fractures in order to minimize their risk of complications and return them to baseline functional capacity

Eligibility Criteria

Inclusion criteria

i) Patients greater than 65 years with any acute rib fracture

ii) Pain score equal to or greater than 5 with deep inspiration.

iii) Presenting and admitted to Stanford Emergency Department

Exclusion criteria

i) Radiographic evidence of metastasis to ribs

ii) Glasgow Coma Scale (GCS) score 1.5, Pat < 100)

vi) Other factors precluding cryoablation at IR attending's discretion

vii) If only ribs broken are 1,2 or 10,11, 12

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04482582). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search